Zobrazeno 1 - 10 of 482 pro vyhledávání: '"Vinsensia, M"'
1
Akademický článek
Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies.
Autor: Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. Eva.Meixner@med.uni-heidelberg.de.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany. Eva.Meixner@med.uni-heidelberg.de.; National Center for Tumor diseases (NCT), Heidelberg, Germany. Eva.Meixner@med.uni-heidelberg.de.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany. Eva.Meixner@med.uni-heidelberg.de., Hoeltgen L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Dinges LA; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany., Seidensaal K; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hoegen-Sassmanshausen P; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany., Vinsensia M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany., Deng M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120, Heidelberg, Germany.; National Center for Tumor diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.
Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.
Zobrazit plný text záznamu
2
Akademický článek
Validation of different automated segmentation models for target volume contouring in postoperative radiotherapy for breast cancer and regional nodal irradiation.
Autor: Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany., Glogauer B; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany., Klüter S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany., Wagner F; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany., Neugebauer D; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany., Hoeltgen L; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Dinges LA; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany., Liermann J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany., Vinsensia M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hoegen-Saßmannshausen P; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heidelberg Ion Therapy Center (HIT), Im Neuenheimer Feld 450, 69120 Heidelberg, Germany.; German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany.
Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2024 Sep 11; Vol. 49, pp. 100855. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Incidence and Risk Assessment of Capsular Contracture in Breast Cancer Patients following Post-Mastectomy Radiotherapy and Implant-Based Reconstruction.
Autor: Vinsensia M; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Schaub R; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Meixner E; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Hoegen P; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Arians N; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Forster T; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Hoeltgen L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Köhler C; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Uzun-Lang K; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Batista V; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany., König L; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany., Zivanovic O; Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Brustzentrum Heidelberg Klinik St. Elisabeth, 69121 Heidelberg, Germany., Hennigs A; Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Brustzentrum Heidelberg Klinik St. Elisabeth, 69121 Heidelberg, Germany., Golatta M; Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Brustzentrum Heidelberg Klinik St. Elisabeth, 69121 Heidelberg, Germany., Heil J; Department of Gynecology and Obstetrics, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Brustzentrum Heidelberg Klinik St. Elisabeth, 69121 Heidelberg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Ion Beam Therapy Center (HIT), Heidelberg University Hospital, 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, 69120 Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), 69120 Heidelberg, Germany.; National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Publikováno v: Cancers [Cancers (Basel)] 2024 Jan 07; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 07.
Zobrazit plný text záznamu
4
Akademický článek
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
Autor: Roesch J; Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany; Deutsches Zentrum Immuntherapie, Erlangen, Germany. Electronic address: johannes.roesch@diestrahlentherapeuten.de., Oertel M; Department of Radiation Oncology, University Hospital Münster, Münster, Germany., Wegen S; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Trommer M; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany., Schleifenbaum J; Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Hering D; Department of Radiation Oncology, University Hospital Münster, Münster, Germany., Mäurer M; Department of Radiation Oncology, University Hospital Jena, Jena, Germany., Knippen S; Department of Radiation Oncology, University Hospital Jena, Jena, Germany., Dobiasch S; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Waltenberger M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., von der Grün J; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany., Medenwald D; Department of Radiation Oncology, University Hospital Halle, Halle, Germany., Süß C; Department of Radiation Oncology, University Hospital Regensburg, Regensburg, Germany., Hoeck M; Department of Radiation Oncology, University Hospital Augsburg, Augsburg, Germany., Käsmann L; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Fleischmann DF; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Rühle A; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Nicolay NH; Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Fabian A; Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany., Löser A; Outpatient Center of the University Medical Hospital Hamburg-Eppendorf, Department of Radiotherapy and Radiation Oncology) and Department of Oncology, Haematology and Bone Marrow Transplantation with the Section Pneumology (Centre for Oncology), University Hospital Hamburg-Eppendorf, Hamburg, Germany., Heß S; Department of Radiation Oncology, University Hospital Würzburg, Julius-Maximilians-University, Würzburg, Germany., Tamaskovics B; Department of Radiation Oncology, Düsseldorf University Hospital, Heinrich Heine University, Düsseldorf, Germany., Vinsensia M; Department of Radiation Oncology, University Hospital Mannheim, Mannheim, Germany., Hecht M; Department of Radiotherapy and Radiation Oncology, Saarland University Medical Center, Homburg/Saar, Germany.
Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Apr; Vol. 181, pp. 109380. Date of Electronic Publication: 2022 Oct 20.
Zobrazit plný text záznamu
6
Akademický článek
Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer.
Autor: Hoeltgen L; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Meixner E; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Hoegen P; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sandrini E; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Weykamp F; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Forster T; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Vinsensia M; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Lang K; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., König L; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Arians N; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Fremd C; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Michel LL; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Smetanay K; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Gynecology and Obstetrics, 27178Heidelberg University Hospital, Heidelberg, Germany., Schneeweiss A; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Wallwiener M; Department of Gynecology and Obstetrics, 27178Heidelberg University Hospital, Heidelberg, Germany., Debus J; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Ion Beam Therapy Center (HIT), Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany., Hörner-Rieber J; Department of Radiation Oncology, 27178Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v: Technology in cancer research & treatment [Technol Cancer Res Treat] 2023 Jan-Dec; Vol. 22, pp. 15330338231164537.
Zobrazit plný text záznamu
8
Low risk and high risk recurrent prostate cancer in 3D Volumetric lymph node assessment based on CT and PSMA11-PET/CT
Autor: Vinsensia, M., Kratochwil, C., Moltz, J., Eiber, M., Afshar-Oromieh, A., Haberkorn, U., Giesel, F.
Introduction PSMA11-PET/CT is a powerful method of detecting early nodal metastases in patients with biochemical relapse. On this retrospective investigation the volume, dimensions and SUVmax of nodes identified by Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)]
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______610::d9764092dc19f19052fcc963fddeb8e9
https://publica.fraunhofer.de/handle/publica/250274
Zobrazit plný text záznamu
9
Akademický článek
[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine.
Autor: Loeff, Cato C.1 (AUTHOR) cato.loeff@radboudumc.nl, van Gemert, Willemijn1 (AUTHOR), Privé, Bastiaan M.1,2 (AUTHOR), van Oort, Inge M.3 (AUTHOR), Hermsen, Rick4 (AUTHOR), Somford, Diederik M.5 (AUTHOR), Nagarajah, James1 (AUTHOR), Heijmen, Linda1,6 (AUTHOR), Janssen, Marcel J. R.1 (AUTHOR)
Publikováno v: EJNMMI Reports. 11/27/2024, Vol. 8 Issue 1, p1-14. 14p.
Zobrazit plný text záznamu
10
Akademický článek
Advanced Imaging for Localized Prostate Cancer.
Autor: Albers, Patrick1 (AUTHOR) palbers@ualberta.ca, Kinnaird, Adam1,2,3,4,5 (AUTHOR) ask@ualberta.ca
Publikováno v: Cancers. Oct2024, Vol. 16 Issue 20, p3490. 18p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje